Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $219.6 in the prior trading day, Cidara Therapeutics Inc (NASDAQ: CDTX) closed at $220.19, up 0.27%. In other words, the price has increased by $0.27 from its previous closing price. On the day, 0.75 million shares were traded. CDTX stock price reached its highest trading level at $220.34 during the session, while it also had its lowest trading level at $219.81.
Ratios:
Our goal is to gain a better understanding of CDTX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.62 and its Current Ratio is at 4.62. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 11 ’25 when Davarpanah Nicole Negar sold 474 shares for $62.86 per share. The transaction valued at 29,797 led to the insider holds 31,418 shares of the business.
RA CAPITAL MANAGEMENT, L.P. bought 2,272,727 shares of CDTX for $99,999,988 on Jun 26 ’25. The Director now owns 3,365,523 shares after completing the transaction at $44.00 per share. On Jun 02 ’25, another insider, Mineo Chrysa, who serves as the Director of the company, bought 2,270 shares for $21.71 each. As a result, the insider paid 49,281 and bolstered with 2,270 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDTX now has a Market Capitalization of 6924162048 and an Enterprise Value of 6504598016.
Stock Price History:
The Beta on a monthly basis for CDTX is 1.52, which has changed by 8.623689 over the last 52 weeks, in comparison to a change of 0.14045572 over the same period for the S&P500. Over the past 52 weeks, CDTX has reached a high of $221.20, while it has fallen to a 52-week low of $15.22. The 50-Day Moving Average of the stock is 49.18%, while the 200-Day Moving Average is calculated to be 224.48%.
Shares Statistics:
The stock has traded on average 1.44M shares per day over the past 3-months and 1028270 shares per day over the last 10 days, according to various share statistics. A total of 29.34M shares are outstanding, with a floating share count of 24.74M. Insiders hold about 21.32% of the company’s shares, while institutions hold 85.72% stake in the company. Shares short for CDTX as of 1764288000 were 2114487 with a Short Ratio of 1.47, compared to 1761868800 on 3203532. Therefore, it implies a Short% of Shares Outstanding of 2114487 and a Short% of Float of 6.7299999999999995.
Earnings Estimates
The stock of Cidara Therapeutics Inc (CDTX) is currently in the spotlight, with 6.0 analysts actively rating and assessing its market standing.The consensus estimate for the next quarter is -$1.64, with high estimates of -$1.64 and low estimates of -$1.64.
Analysts are recommending an EPS of between -$5.47 and -$9.16 for the fiscal current year, implying an average EPS of -$8.07. EPS for the following year is -$6.29, with 5.0 analysts recommending between -$4.05 and -$10.06.
